← Back
Data updated: Mar 10, 2026
SCS
Cardiovascular
SCS is a generic drug manufacturer focused on Cardiovascular.
1992
Since
4
Drugs
-
Trials
57
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
HALOPERIDOL 2025-12-18
PIROXICAM 2025-09-12
Labeling
ATENOLOL 2025-07-30
Labeling
ATENOLOL 2025-07-29
Labeling
ATENOLOL 2025-07-29
Labeling
ATENOLOL 2025-07-29
Labeling
ATENOLOL 2025-07-29
Labeling
ATENOLOL 2025-07-29
Labeling
ATENOLOL 2025-07-29
Labeling
ATENOLOL 2025-03-17
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (3)
Company Info
- First Approval
- 1992-05-29
- Latest
- 1994-03-25
- Applications
- 10